시스테인 시장 보고서 : 제조 프로세스, 용도, 최종 용도 산업 및 지역별(2026-2034년)

The global cysteine market size reached USD 441.1 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 629.1 Million by 2034, exhibiting a growth rate (CAGR) of 3.90% during 2026-2034. The expanding pharmaceutical and personal care industries, increasing applications in the F&B sector, the surging demand for health supplements, etc., are primarily propelling the market growth.

Cysteine Market Trends:

Increasing Utilization in the Formulation of Pharmaceutical Drugs

The increasing utilization of cysteine in the formulation of pharmaceutical drugs is significantly driving the growth of the cysteine market. Cysteine plays a crucial role in the formulation of pharmaceutical drugs due to its biochemical properties and therapeutic benefits. It is used in various drug formulations to enhance efficacy, stability, and bioavailability. For instance, according to an article published by Healthline, consuming enough cysteine is beneficial for various reasons, including replenishing the body's most powerful antioxidant, glutathione. These amino acids are also beneficial for curing respiratory issues, fertility, and brain function. Moreover, cysteine is used in formulations targeting chronic diseases such as cardiovascular disorders, respiratory diseases, and neurological ailments. It can aid in the production of cellular glutathione levels and support liver function. For instance, in December 2022, Jarrow Formulas, a probiotic brand focused on customer satisfaction, launched N-A-C, a vegetarian capsule containing 500mg of N-Acetyl-L-Cysteine. The product offering is a potent antioxidant amino acid that also serves as a precursor in the body to the key antioxidant glutathione - one of the body's most significant and abundant antioxidant and detoxifying agents that promotes liver health. These factors are further contributing to the cysteine market share.

Rising Demand for Plant-Based Alternatives

The increasing demand for plant-based alternatives is significantly driving growth in the cysteine market, particularly due to the role of cysteine in food and beverage products. As consumer preferences shift towards vegetarian or vegan diets, there is a growing demand for plant-based alternatives in various food and beverage categories. Cysteine, traditionally sourced from animal by-products like feathers or human hair, is now being produced through biotechnological processes or extracted from plant-based sources to cater to this demand. For instance, in January 2022, Danish biotech company, Biosyntia, and Munich-based, Wacker Group, planned to expand the production of fermentation-based biotin across Europe. This biotin was available as a dietary supplement and has potential applications in food & drinks, infant nutrition, and nutraceuticals. Wacker Biosolutions focuses on developing solutions for growth sectors, with products including fermentation-based L-Cysteine and cyclodextrins, and silicone sealants from plant-based ethanol. This is further driving the cysteine industry's growth. Besides this, plant-based diets are often perceived as healthier choices due to their potential benefits for heart health, weight management, and sustainability. For instance, according to an article published by the National Library of Medicine, plant-based diets can reduce all-cause mortality as well as the risk of ischemic heart disease, which is associated with lower IHD mortality. It can also improve blood pressure, glucose, and cholesterol control, reducing the need for drugs. Cysteine derived from plant sources aligns with these health and wellness trends, appealing to health-conscious consumers. These factors are further bolstering the cysteine market revenue.

Growing Food Processing Industry

The growing baking industry is one of the significant factors driving the market growth. For instance, according to the American Bakers Association, the American bakery industry has USD 186 billion in overall economic impact. Cysteine is commonly used as a dough conditioner in baked goods such as bread, pastries, and pizza crusts. It improves dough elasticity, texture, and volume, leading to better product quality and consistency. Apart from this, the food processing industry is also gaining significant growth which is further propelling the demand for cysteine. According to an article published by the India Brand Equity Foundation, the food processing sector has received an impressive average annual growth rate of 7.3% from 2015 to 2022. Also, in November 2023, the Ministry of Food Processing Industries hosted the 'World Food India" event, in New Delhi. Apart from this, the increasing demand for processed and convenience foods globally is driving the need for ingredients like cysteine that improve processing efficiency and product shelf life while maintaining sensory attributes. For instance, according to research published by the National Library of Medicine, cysteine can delay spoilage and extend the shelf life of patties. These factors are further positively impacting the cysteine market forecast.

Global Cysteine Industry Segmentation:

The publisher provides an analysis of the key trends in each segment of the global cysteine market report, along with forecasts at the global, regional, and country levels from 2026-2034. Our report has categorized the market based on production process, application, and end use industry.

Breakup by Production Process:

• Natural
• Synthetic

Currently, synthetic holds the majority of the total market share

According to the cysteine market outlook, advances in chemical synthesis, enzymatic processes, and biotechnological methods have significantly improved the efficiency and cost-effectiveness of synthetic cysteine production. Continuous innovation in production techniques enhances scalability and reduces production costs, making synthetic cysteine more competitive compared to traditional extraction methods. Moreover, the increasing demand for cysteine as a food additive, particularly in the bakery and processed food sectors, is a major driver for synthetic production. Synthetic cysteine offers manufacturers a consistent and reliable source of amino acid, ensuring product quality and compliance with regulatory standards. Apart from this, the rising health benefits of synthetic cysteine is also driving the market growth. For instance, according to an article published by Forbes, NAC, a synthetic form of cysteine, may be an effective treatment for certain respiratory conditions, such as chronic bronchitis or chronic obstructive pulmonary disease.

Breakup by Application:

• Conditioner
• Flavor Enhancer
• Reducing Agent
• Human Insulin Production
• Others

Flavor enhancer currently exhibits a clear dominance in the market

According to the cysteine market overview, cysteine is valued for its ability to enhance umami flavors and improve overall taste perception in food products. This makes it particularly sought after in savory and baked goods where rich, savory notes are desired. Moreover, cysteine's versatility allows it to be used in a wide range of food applications, including bakery products (e.g., bread, pastries, pizza crusts), snacks, soups, sauces, and processed meats. Its effectiveness in improving flavor profiles across diverse product categories contributes to its consistent demand. For instance, according to a sensory analysis published by Springer Nature in December 2023, 0.25-0.75% range of cysteine increased the meaty, caramel, umami, mouthfulness and salty notes, and caused a decrease in bitter taste of the MRPs as confirmed by GC-MS.

Breakup by End Use Industry:

• Food and Dietary Supplement
• Pharmaceutical
• Cosmetic
• Animal Feed
• Others

Currently, food and dietary supplement accounts for the largest market share

Cysteine is a precursor to glutathione, a powerful antioxidant that helps protect cells from oxidative stress and supports overall immune health. Consumers are increasingly seeking supplements that provide antioxidant support to combat the effects of free radicals and promote cellular health. Moreover, glutathione, synthesized from cysteine, plays a crucial role in detoxifying harmful substances in the liver and other tissues. Dietary supplements containing cysteine are sought after for their potential to support liver function and aid in detoxification processes. For instance, in May 2024, Plexus Worldwide, a health and wellness company, launched IronWoman, an iron supplement specifically formulated for the unique needs of women. The supplement was made by combining L Plantarum strain, with cysteine, and Vitamin C to create a combination that offers superior iron absorption.

Breakup by Region:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

Asia Pacific accounts for the largest market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Asia Pacific currently dominates the global market.

According to the cysteine market statistics, the Asia Pacific region has a rapidly growing food industry, fueled by urbanization, changing dietary habits, and increasing disposable incomes. Cysteine is widely used as a food additive, particularly in baked goods and savory products, to enhance flavor and texture. The rising demand for processed and convenience foods along with the growing fast-food industry further drives the market for cysteine in this region. For instance, the National Bureau of Statistics of China reports that in 2022, full-service restaurants brought in Yuan 502.94 billion (USD 70.98 billion) in income, while fast-food restaurants brought in Yuan 157.82 billion (USD 22.24 billion). This observed the expansion of China's food industry. Moreover, with a rising awareness of health and wellness among consumers, there is an increasing demand for dietary supplements containing cysteine. Asian consumers are widely adopting supplements for antioxidant support, respiratory health, and overall well-being, contributing to the growth of the cysteine supplement market.

Competitive Landscape:

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major market companies have also been provided. Some of the key players in the market include:

• Ajinomoto Co. Inc.
• CJ CheilJedang Corp.
• Merck KGaA
• Nippon Rika Co. Ltd
• Shanghai Cosroma Biotech Co. Ltd
• Shine Star (Hubei) Biological Engineering Co. Ltd.
• Wacker Chemie AG
• Wuhan Grand Hoyo Co. Ltd. (Grand Pharma (China) Co. Ltd.)
• Wuxi Bikang Bioengineering Co. Ltd.

Key Questions Answered in This Report

• 1.How big is the global cysteine market?
• 2.What is the expected growth rate of the global cysteine market during 2026-2034?
• 3.What are the key factors driving the global cysteine market?
• 4.What has been the impact of COVID-19 on the global cysteine market?
• 5.What is the breakup of the global cysteine market based on the production process?
• 6.What is the breakup of the global cysteine market based on the application?
• 7.What is the breakup of the global cysteine market based on the end-use industry?
• 8.What are the key regions in the global cysteine market?
• 9.Who are the key players/companies in the global cysteine market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Cysteine Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Production Process

• 6.1 Natural
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Synthetic
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast

7 Market Breakup by Application

• 7.1 Conditioner
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Flavor Enhancer
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Reducing Agent
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Human Insulin Production
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast
• 7.5 Others
  • 7.5.1 Market Trends
  • 7.5.2 Market Forecast

8 Market Breakup by End Use Industry

• 8.1 Food and Dietary Supplement
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Pharmaceutical
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Cosmetic
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Animal Feed
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast
• 8.5 Others
  • 8.5.1 Market Trends
  • 8.5.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Ajinomoto Co. Inc.
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
    • 14.3.1.3 Financials
    • 14.3.1.4 SWOT Analysis
  • 14.3.2 CJ CheilJedang Corp.
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
    • 14.3.2.3 Financials
  • 14.3.3 Merck KGaA
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
    • 14.3.3.3 Financials
    • 14.3.3.4 SWOT Analysis
  • 14.3.4 Nippon Rika Co. Ltd
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
  • 14.3.5 Shanghai Cosroma Biotech Co. Ltd
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
  • 14.3.6 Shine Star (Hubei) Biological Engineering Co. Ltd.
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
  • 14.3.7 Wacker Chemie AG
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
    • 14.3.7.3 Financials
    • 14.3.7.4 SWOT Analysis
  • 14.3.8 Wuhan Grand Hoyo Co. Ltd. (Grand Pharma (China) Co. Ltd.)
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
  • 14.3.9 Wuxi Bikang Bioengineering Co.Ltd.
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio